• A breakthrough in yeast genome engineering by scientists from the ARC Centre of Excellence in Synthetic Biology, Macquarie University, and the Australian Wine Research Institute (AWRI) is a game changer for industry. (Image source: AWRI)
    A breakthrough in yeast genome engineering by scientists from the ARC Centre of Excellence in Synthetic Biology, Macquarie University, and the Australian Wine Research Institute (AWRI) is a game changer for industry. (Image source: AWRI)
Close×

A breakthrough in yeast genome engineering by scientists from the ARC Centre of Excellence in Synthetic Biology, Macquarie University, and the Australian Wine Research Institute (AWRI) is a possible game changer for industry.

AWRI research manager Dr Anthony Borneman and the study’s lead author said it was a proof of concept that entirely new chromosomes can be built for specific industrial purposes.

“Unique genomic sequences from a range of yeast strains – including those used in wine, sake, and biofuel production – were assembled into a completely new chromosome in the laboratory strain.

“This additional genetic material imparted new characteristics, such as allowing the laboratory strain to ferment sugars it normally can’t use, widening the feedstocks available for industrial purposes,” Borneman said.

The research is an extension of a global engineered yeast project, Sc2.0, which is attempting to synthesise the entire genome of the yeast Saccharomyces cerevisiae.

Saccharomyces cerevisiae is an industrial workhorse, AWRI said, having been used in brewing, distilling, winemaking, and baking for thousands of years.

More recently, it has been important for producing ethanol for E10 petrol and a wide variety of industrial biochemicals.

The overall goal of this work was to address the lack of genetic variation in the Sc2.0 strain that could limit future industrial application.

The project aims to help researchers understand how a yeast genome is organised and how genomes might be improved to create more robust organisms.

It also provides a foundation for future specific purposes, such as creating new medications or biofuels. Macquarie University, the ARC Centre of Excellence in Synthetic Biology and the AWRI are partners in the Sc2.0 collaboration.

Packaging News

Pact Group will delist from the ASX on Wednesday 16 July, the move being the culmination of executive chair and owner Raphael Geminder’s near two-year bid to take full control of the company.

Packaging is at the heart of Suntory’s bold new chapter in Australia, marked by the opening of its $400 million beverage production facility in Swanbank, Queensland – a site purpose-built to deliver high-speed, high-efficiency bottling, canning and kegging through world-class packaging technology and sustainable design.

Ego Pharmaceuticals has unveiled a bold new chapter in its commitment to local manufacturing, announcing a $156 million, decade-long investment to expand its Victorian operations.